Not Tagged
avencell therapeutics
['leukemia', 'myeloid', 'congrat', 'avencell']
congrats to the avencell team on the excellent clinical data presented at #ash22 for patients with relapsed/refractory acute myeloid leukemia! 31% cri in first 16 patients. sincere thx to the patients and their families. 
President & Chief Executive Officer, AvenCell Therapeutics, passionate about Oncology, Immunology, gene editing, cell therapy and global health.